EcoDrugPlus

Adenosine A2a Receptor

Ensembl ID : ENSMMDG00005016540
Gene Symbol: ADORA2A
1 Cross references
198 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSMMDG00005000720
Gene Symbol: ADORA2AA
1 Cross references
189 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSMMDG00005020997
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSMMDG00005001020
Gene Symbol: ADORA3
1 Cross references
145 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSMMDG00005013034
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSMMDG00005000152
Gene Symbol: LOC115362570
2 Cross references
39 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSMMDG00005011503
Gene Symbol: ADRM1
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSMMDG00005009221
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSMMDG00005015804
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSMMDG00005015693
Gene Symbol: ADRA1B
1 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSMMDG00005001002
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSMMDG00005016494
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).